Author

H. A. Kessler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:metagenomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Grier· 2 shared A. L. Gill· 2 shared A. R. Falsey· 2 shared D. J. Topham· 2 shared J. Holden-Wiltse· 2 shared M. T. Caserta· 2 shared S. Bandyopadhyay· 2 shared S. R. Gill· 2 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Grier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection

A. Grier, A. L. Gill, H. A. Kessler, A. Corbett, S. Bandyopadhyay, J. Java, J. Holden-Wiltse, A. R. Falsey, D. J. Topham, T. J. Mariani, M. T. Caserta, E. E. Walsh, S. R. Gill

This study examines the temporal changes in infant nasal microbiota relative to RSV infection and identifies taxa associated with infection and disease severity.

The Journal of Infectious Diseases · Sep 14, 2020Peer-reviewedMicrobiology

Aberrant newborn T cell and microbiota developmental trajectories predict respiratory compromise during infancy

A. Grier, N. Laniewski, A. L. Gill, H. A. Kessler, H. Huyck, J. Holden-Wiltse, S. Bandyopadhyay, J. Carnahan, A. M. Dylag, D. J. Topham, A. R. Falsey, M. T. Caserta, G. S. Pryhuber, S. R. Gill, A. McDavid, K. M. Scheible

The paper identifies that prenatal antibiotics or infection disrupt T cell and microbiota development, increasing respiratory morbidity risk in infants.

bioRxiv · Jun 16, 2020 · PreprintImmunology